Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen

Scandinavian Journal of Urology and Nephrology

Volumn 41, Issue 4, 2007, Pages 290-296

  Liedberg, Fredrik ^a   Anderson, Harald ^a   Bläckberg, Mats ^b   Chebil, Gunilla ^b   Davidsson, Thomas ^a   Gudjonsson, Sigurdur ^a   Jahnson, Staffan ^c   Olsson, Hans ^c   Månsson, Wiking ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HELSINGBORG HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Carcinoma in situ; Prostate; Radical cystoprostatectomy; Transitional cell carcinoma

Indexed keywords

BCG VACCINE;

AGED; ARTICLE; BLADDER; BLADDER NECK; BLADDER TUMOR; CANCER GRADING; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CARCINOMA IN SITU; CYSTECTOMY; DIAGNOSTIC VALUE; EVALUATION; HUMAN; HUMAN TISSUE; INFORMATION; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE; PROSTATE CANCER; PROSTATIC URETHRA CARCINOMA; TRANSITIONAL CELL CARCINOMA; TUMOR BIOPSY; TUMOR GROWTH; TUMOR LOCALIZATION; URETHRA CARCINOMA;

AGE FACTORS; AGED; BCG VACCINE; BIOPSY; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; URETHRAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 34548412213     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590601183576     Document Type: Article

References (20)

1. Sawczuk I, Tannenbaum M, Olsson CA, deVere White R. Primary transitional cell carcinoma of prostatic periurethral ducts. Urology 1985;25:339-43.
2. Schellhammer PF, Bean MA, Whitmore WF Jr. Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis. J Urol 1977;118:399-403.
3. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2004;171:646-51.
4. Pagano F, Bassi P, Ferrante GL, Piazza N, Abatangelo G, Pappagallo GL, et al. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement. J Urol 1996;155:244-7.
5. Esrig D, Freeman JA, Elmajian DA, Stein JP, Chen SC, Groshen S, et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996;156:1071-6.
6. Freeman JA, Tarter TA, Esrig D, Stein JP, Elmajian DA, Chen SC, et al. Urethral recurrence in patients with orthotopic ileal neobladders. J Urol 1996;156:1615-9.
7. Nixon RG, Chang SS, Lafleur BJ, Smith JJ, Cookson MS. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J Urol 2002;167:502-5.
8. Donat SM, Wei DC, McGuire MS, Herr HW. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol 2001;165:1580-4.
9. Reese JH, Freiha FS, Gelb AB, Lum BL, Torti FM. Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy. J Urol 1992;147:92-5.
10. Wood DP Jr, Montie JE, Pontes JE, Levin HS. Identification of transitional cell carcinoma of the prostate in bladder cancer patients: a prospective study. J Urol 1989;142:83-5.
11. Donat SM, Genega EM, Herr HW, Reuter VE. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 2001;165:1117-20.
12. Njinou Ngninkeu B, Lorge F, Moulin P, Jamart J, Van Cangh PJ. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol 2003;169:149-52.
13. Liedberg F, Chebil G, Mansson W. Hematogenous dissemination of transitional cell carcinoma in the bladder to the prostate. Scand J Urol Nephrol 2003;37:359-60.
14. Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004;171:135-8.
15. Sakamoto N, Tsuneyoshi M, Naito S, Kumazawa J. An adequate sampling of the prostate to identify prostatic involvement by urothelial carcinoma in bladder cancer patients. J Urol 1993;149:318-21.
16. Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol 2005;173:1163-8.
17. Lebret T, Herve JM, Barre P, Gaudez F, Lugagne PM, Barbagelatta M, et al. Urethral recurrence of transitional cell carcinoma of the bladder. Predictive value of preoperative latero-montanal biopsies and urethral frozen sections during prostatocystectomy. Eur Urol 1998;33:170-4.
18. Hall RH, Robinson MC. Transitional cell carcinoma of the prostate. Eur Urol Update Ser 1998;7:1-7.
19. Solsona E, Iborra I, Dumont R, Rubio J, Casanova JL, Almenar S. Risk groups in patients with bladder cancer treated with radical cystectomy: statistical and clinical model improving homogeneity. J Urol 2005;174:1226-30.
20. Vallancien G, Abou El Fettouh H, Cathelineau X, Baumert H, Fromont G, Guillonneau B. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J Urol 2002;168:2413-7.